MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/03/6306-1437-1447$20.00
Mol Pharmacol 63:1437-1447, 2003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ceruti, S.
Right arrow Articles by Abbracchio, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ceruti, S.
Right arrow Articles by Abbracchio, M. P.

A Key Role for Caspase-2 and Caspase-3 in the Apoptosis Induced by 2-Chloro-2'-deoxy-adenosine (Cladribine) and 2-Chloro-adenosine in Human Astrocytoma Cells

Stefania Ceruti, Elena Beltrami, Paola Matarrese, Alessia Mazzola, Flaminio Cattabeni, Walter Malorni , and Maria P. Abbracchio

Department of Pharmacological Sciences, School of Pharmacy (S.C., E.B., A.M., F.C., M.P.A.) and Center of Excellence for Neurodegenerative Diseases (S.C., F.C., M.P.A.), University of Milan, Milan, Italy; and Department of Ultrastructures, Istituto Superiore di Sanitá, Rome, Italy (P.M., W.M.)

Both the anticancer agent 2-chloro-2'-deoxy-adenosine (Cladribine) and its derivative 2-chloro-adenosine induce apoptosis of human astrocytoma cells (J Neurosci Res 60:388–400, 2000). In this study, we have analyzed the involvement of caspases in these effects. Both compounds produced a gradual and time-dependent activation of "effector" caspase-3, which preceded the appearance of the nuclear signs of apoptosis, suggesting a temporal correlation between these two events. Moreover, the caspase inhibitor N-benzyloxycarbonyl-Val-Ala-DL-Asp-fluoromethylketone (fmk) suppressed both caspase-3 activation and apoptosis induction. "Initiator" caspase-9 and caspase-8 were only marginally activated at later times in the apoptotic process. Accordingly, at concentrations that selectively inhibit these caspases, neither N-benzyloxycarbonyl-Leu-Glu-His-Asp-fmk nor N-benzyloxycarbonyl-Ile-Glu-Thr-Asp-fmk could prevent adenosine analog-induced cell death. To definitively rule out a role for the caspase-9/cytochrome c-dependent mitochondrial pathway of cell death, neither adenosine analog had any effect on mitochondrial membrane potential, which was instead markedly reduced by other apoptotic stimuli (e.g., deoxyribose, NaCN, and betulinic acid). Consistently, although the latter triggered translocation of mitochondrial cytochrome c to the cytoplasm, no cytosolic accumulation of cytochrome c was detected with adenosine analogs. Conversely, 1 to 7 h after addition of either adenosine analog (i.e., before the appearance of caspase-3 activation), caspase-2 activity was surprisingly and markedly increased. The selective caspase-2 inhibitor N-benzyloxy carbonyl-Val-Asp-Val-Ala-Asp-fmk significantly reduced both adenosine analogs-induced caspase-2 activation and the associated cell death. We conclude that adenosine analogs induce the apoptosis of human astrocytoma cells by activating an atypical apoptotic cascade involving caspase-2 as an initiator caspase, and effector caspase-3. Therefore, these compounds could be effectively used in the pharmacological manipulation of tumors characterized by resistance to cell death via either the mitochondrial or caspase-8/death receptor pathways.


Received November 25, 2002; accepted March 14, 2003.

Address correspondence to: Prof. Maria P. Abbracchio-Department of Pharmacological Sciences, University of Milan and Center of Excellence for Neurodegenerative Diseases (CEND)-Via Balzaretti, 9-20133 Milan, Italy. E-mail: mariapia.abbracchio{at}unimi.it




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
J. Wang, Y. Jin, Z. Xu, Z. Zheng, and S. Wan
Involvement of Caspase-3 Activity and Survivin Downregulation in Cinobufocini-Induced Apoptosis in A 549 Cells
Experimental Biology and Medicine, May 1, 2009; 234(5): 566 - 572.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. M. Giammarioli, A. Maselli, A. Casagrande, L. Gambardella, A. Gallina, M. Spada, A. Giovannetti, E. Proietti, W. Malorni, and M. Pierdominici
Pyrimethamine Induces Apoptosis of Melanoma Cells via a Caspase and Cathepsin Double-Edged Mechanism
Cancer Res., July 1, 2008; 68(13): 5291 - 5300.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
R. P. C. Wong, W. P. Tsang, P. Y. Chau, N. N. Co, T. Y. Tsang, and T. T. Kwok
p53-R273H gains new function in induction of drug resistance through down-regulation of procaspase-3
Mol. Cancer Ther., March 1, 2007; 6(3): 1054 - 1061.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Ceruti, A. Mazzola, and M. P. Abbracchio
Proteasome Inhibitors Potentiate Etoposide-Induced Cell Death in Human Astrocytoma Cells Bearing a Mutated p53 Isoform
J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1424 - 1434.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Ceruti, A. Mazzola, and M. P. Abbracchio
Resistance of Human Astrocytoma Cells to Apoptosis Induced by Mitochondria-Damaging Agents: Possible Implications for Anticancer Therapy
J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 825 - 837.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Qin, T. L. Vanden Hoek, K. Wojcik, T. Anderson, C.-Q. Li, Z.-H. Shao, L. B. Becker, and K. J. Hamann
Caspase-dependent cytochrome c release and cell death in chick cardiomyocytes after simulated ischemia-reperfusion
Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2280 - H2286.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics